In 2024, the Advisory Committee on Immunization Practices (ACIP) updated guidance on pneumococcal vaccination to include pneumococcal conjugate vaccine 21 (PCV21) alone as an additional option [15]. Since PCV21 contains eleven serotypes that are common causes of invasive pneumococcal disease in ...